Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Clinical trial NCT05011266 · RECRUITING
Trial details
- NCT number
- NCT05011266
- Sponsor
- New York State Psychiatric Institute
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-18
- Primary completion
- 2027-01-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.